11 Results for "

Drug-resistant malaria

" in MedChemExpress (MCE) Product Catalog:
Products (11)

11 Results for "Drug-resistant malaria" in MCE Product Catalog:

3
3 Cited Publications
Cat. No.: HY-N0402
CAS No.: 71963-77-4
Synonyms: Dihydroqinghaosu methyl ether; Dihydroartemisinin methyl ether; SM224
Artemether is an anti-malarial compound that targets drug-resistant strains of falciparum malaria .
loading...
    loading...
Cat. No.: HY-N0402R
CAS No.: 71963-77-4
Synonyms: Dihydroqinghaosu methyl ether (Standard); Dihydroartemisinin methyl ether (Standard); SM224 (Standard)
Artemether (Standard) is the analytical standard of Artemether. This product is intended for research and analytical applications. Artemether is an anti-malarial compound that targets drug-resistant strains of falciparum malaria .
loading...
    loading...
Cat. No.: HY-124112
CAS No.: 13794-65-5
Target:  

Parasite

Research Areas:  

Infection

PAM 1392 is active orally against Plasmodium berghei in mice, P. cynofologi and P. knowlesi in monkeys and Trypanosoma cruzi in tissue cultures of mice, and hemolytic streptococci in vitro. PAM 1392 has antimalarial and antitrypanosomal activities, which is proming for rasearch of drug-resistant malaria .
loading...
    loading...
Cat. No.: HY-W768856
Synonyms: Dihydroqinghaosu methyl ether-13C,d3; Dihydroartemisinin methyl ether-13C,d3; SM224-13C,d3
Artemether- 13C,d3 (Dihydroqinghaosu methyl ether- 13C,d3) is the deuterium and 13C-labeled Artemether (HY-N0402). Artemether is an anti-malarial compound that targets drug-resistant strains of falciparum malaria .
loading...
    loading...
Cat. No.: HY-A0130R
CAS No.: 152-47-6
Synonyms: Sulfametopyrazine (Standard); AS-18908 (Standard)
Research Areas:  

Infection

Sulfalene (Standard) is the analytical standard of Sulfalene. This product is intended for research and analytical applications. Sulfalene (Sulfametopyrazine; AS-18908) is an orally active antimalarial agent. Sulfalene competes for para-aminobenzoic acid binding in plasmodial folic acid synthesis. Sulfalene, combined with Trimethoprim (HY-B0510), clears parasites, resolves fever, and resists induced resistance against drug-sensitive and drug-resistant Plasmodium falciparum. Sulfalene can be used for the research of acute falciparum malaria and Schistosoma mansoni infection .
loading...
    loading...
Cat. No.: HY-178147
Target:  

Parasite

Research Areas:  

Infection

Antimalarial agent 52 is an orally active formation of synthetic hemozoin (β-hematin) inhibitor with an IC50 of 6.6 μM. Antimalarial agent 52 exhibits in vitro antiplasmodial activity against P. falciparum Pf3D7, PfDd2 strains and P. knowlesi with IC50s of 6.1, 6.4 and 3.3 nM. Antimalarial agent 52 remain highly effective against multidrug-resistant strains and demonstrates curative activity in the P. berghei mouse model .
loading...
    loading...
Cat. No.: HY-155054
CAS No.: 3051934-95-0
Target:  

Parasite

Research Areas:  

Infection

Cysteine protease inhibitor-3 (Compound 15) is a Cysteine protease inhibitor. Cysteine protease inhibitor-3 inhibits Pf3D7, PfW2, PfFP2 and PfFP3 with IC50s of 0.74 μM, 1.05 μM, 3.5 μM, and 4.9 μM, respectively. Cysteine protease inhibitor-3 has anti-plasmodial efficacy against both drug-sensitive and drug-resistant parasites .
loading...
    loading...
Cat. No.: HY-186053
CAS No.: 1220533-66-3
Target:  

Parasite

Research Areas:  

Infection

Antimalarial agent 56 is an orally active antimalarial agent. Antimalarial agent 56 inhibits the growth of both drug-sensitive and drug-resistant Plasmodium falciparum strains in vitro. Antimalarial agent 56 can be used in malaria research .
loading...
    loading...
Cat. No.: HY-187367
Research Areas:  

Infection

WJM590 is an orally active antimalarial agent that also exhibits inhibitory activities against renin, cathepsin D, BACE1, and plasmodial aspartic proteases. WJM590 inhibits substrate and protein maturation processing mediated by key proteases of Plasmodium falciparum, arrests asexual blood-stage parasites at the late schizont stage, inhibits merozoite release, and blocks malaria parasite transmission via vectors. WJM590 exerts selective inhibitory activity against multiple Plasmodium species and drug-resistant Plasmodium falciparum strains, and reduces parasitemia in infected mice. WJM590 can be used in malaria-related research .
loading...
    loading...
Cat. No.: HY-182348
Target:  

Parasite

Research Areas:  

Infection

LSPN959 is a slow-acting indole peptidomimetic antiplasmodial agent with submicromolar activity against the Plasmodium falciparum 3D7 strain. LSPN959 does not inhibit plastid-dependent isoprenoid biosynthesis. The combination of LSPN959 with Artesunate (HY-N0193) exhibits an additive effect against Plasmodium falciparum. LSPN959 can be used in malaria research .
loading...
    loading...
Cat. No.: HY-184395
Target:  

Parasite

Research Areas:  

Infection

HLQ-102 is an orally active parasite cytochrome bc1 complex Qi site binder. HLQ-102 inhibits the growth of Plasmodium. HLQ-102 exhibits antimalarial activity against Plasmodium in mice. HLQ-102 can be used in malaria-related research .
loading...
    loading...
  • 1